Hepatitis B and hepatitis C in emergency department patients.

Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev (2000) 2.45

Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol (2008) 2.27

The management of needlestick injuries. Dtsch Arztebl Int (2013) 1.89

Hepatitis viruses: changing patterns of human disease. Proc Natl Acad Sci U S A (1994) 1.60

Evaluation of the Centers for Disease Control and Prevention Recommendations for Hepatitis C Virus Testing in an Urban Emergency Department. Clin Infect Dis (2016) 1.44

Hepatitis C: progress and problems. Clin Microbiol Rev (1994) 1.37

Epidemiology of primary and secondary liver cancers. Semin Intervent Radiol (2006) 1.25

Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada. J Urban Health (2004) 1.10

Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation. J Clin Invest (1994) 1.09

Hepatitis C in HIV-infected individuals: cure and control, right now. J Int AIDS Soc (2011) 1.03

Interaction of alcohol and hepatitis C virus infection on severity of liver disease. Dig Dis Sci (1999) 0.96

Risk factors for the transmission of hepatitis C virus infection in the Turkish population. Dig Dis Sci (2006) 0.95

Prevalence of blood-borne pathogens in an urban, university-based general surgical practice. Ann Surg (2005) 0.95

Brief intervention to increase emergency department uptake of combined rapid human immunodeficiency virus and hepatitis C screening among a drug misusing population. Acad Emerg Med (2014) 0.91

High prevalence of anti-HCV antibodies in two metropolitan emergency departments in Germany: a prospective screening analysis of 28,809 patients. PLoS One (2012) 0.91

Improvements in the continuum of HIV care in an inner-city emergency department. AIDS (2016) 0.91

Clinical sequelae of hepatitis C acquired from injection drug use. West J Med (1996) 0.88

Hepatitis B and C in African Americans: current status and continued challenges. Clin Gastroenterol Hepatol (2013) 0.87

Hepatitis virus infection and liver disease in injecting drug users who died suddenly. J Clin Pathol (1996) 0.87

Public health clinic-based hepatitis C testing and linkage to care in baltimore. J Viral Hepat (2016) 0.86

Differences in hepatitis C virus prevalence and clearance by mode of acquisition among men who have sex with men. J Viral Hepat (2013) 0.85

Estimating HCV prevalence at the state level: a call to increase and strengthen current surveillance systems. Am J Public Health (2013) 0.85

Prevalence and associated factors of viral hepatitis and transferrin elevations in 5036 patients admitted to the emergency room of a Swiss university hospital: cross-sectional study. BMC Gastroenterol (2007) 0.83

Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans with severe mental illness. J Natl Med Assoc (2004) 0.82

Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites, 2012-2014. Public Health Rep (2016) 0.82

Senior Center-Based Hepatitis C Screening in Baltimore. Open Forum Infect Dis (2016) 0.81

Prevalence of hepatitis B and C markers in high-risk hospitalised patients in Crete: a five-year observational study. BMC Public Health (2001) 0.79

Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women. Dig Dis Sci (2012) 0.79

Assessment of liver histology in chronic alcoholics with and without hepatitis C virus infection. Dig Dis Sci (2001) 0.79

Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department. Clin Infect Dis (2016) 0.78

Viral hepatitis and the surgeon. HPB (Oxford) (2005) 0.77

Hepatitis B, Hepatitis C and HIV seroprevalence in critically ill emergency medicine department patients in a tertiary inner city hospital in Istanbul, Turkey. Pak J Med Sci (2014) 0.76

Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion. Ann Surg (1994) 0.76

Characterizing Failure to Establish Hepatitis C Care of Baby Boomers Diagnosed in the Emergency Department. Open Forum Infect Dis (2016) 0.75

Hepatitis B in the emergency department. N Engl J Med (1992) 0.75

HBV & HCV - awareness in acute abdomen emergency cases. J Clin Diagn Res (2014) 0.75

A Training Model for Implementing Hepatitis Prevention Services in Substance Use Disorder Clinics: A Qualitative Evaluation. J Gen Intern Med (2015) 0.75

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature (1997) 15.49

Natural history of progression after PSA elevation following radical prostatectomy. JAMA (1999) 14.35

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med (1999) 12.68

DNA polymerase associated with human hepatitis B antigen. J Virol (1973) 10.71

Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet (1999) 10.28

Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci U S A (1990) 8.92

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med (1989) 8.10

HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet (1997) 7.52

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA (1992) 6.40

A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production. J Hyg (Lond) (1966) 6.23

Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol (1993) 6.21

Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A (1997) 6.09

A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A (1997) 6.07

Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med (1966) 5.97

AIDS in Africa: an epidemiologic paradigm. Science (1986) 5.88

Color test for the measurement of antibody to T-strain mycoplasmas. J Bacteriol (1966) 5.61

Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis (1995) 5.53

Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A (1991) 5.51

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science (2000) 5.49

Sex differences in HIV-1 viral load and progression to AIDS. Lancet (1998) 5.24

Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1994) 5.15

Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS (2000) 5.14

delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A (1980) 5.12

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med (1999) 5.05

An African primate lentivirus (SIVsm) closely related to HIV-2. Nature (1989) 5.03

Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS (1988) 4.85

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A (1996) 4.82

A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med (1991) 4.79

Chlamydia trachomatis infections in female military recruits. N Engl J Med (1998) 4.68

A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. Proc Natl Acad Sci U S A (2001) 4.62

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol (1993) 4.55

Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol (1987) 4.49

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology (1990) 4.43

Azithromycin in control of trachoma. Lancet (1999) 4.32

Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis (1980) 4.28

Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med (1991) 4.24

Characterization of Campylobacter-like organisms isolated from homosexual men. J Infect Dis (1984) 4.23

Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science (1995) 4.19

Spread of HIV infection in married monogamous women in India. JAMA (1997) 4.18

Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15

Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol (1993) 4.13

Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA (1998) 4.12

Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras. Virology (1999) 4.04

Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection. Ann Intern Med (1982) 3.95

Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis (1994) 3.93

Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol (2002) 3.83

Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol (1998) 3.73

Sequence analysis of the 5' noncoding region of hepatitis C virus. Proc Natl Acad Sci U S A (1992) 3.72

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med (1997) 3.71

Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (1999) 3.69

Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Sci U S A (1989) 3.67

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A (1994) 3.56

Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci U S A (1992) 3.55

A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS (1998) 3.54

A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody. J Immunol (1976) 3.53

Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol (2003) 3.50

Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol (1995) 3.44

Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol (2000) 3.44

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. JAMA (2001) 3.41

Risk factors for HIV infection in people attending clinics for sexually transmitted diseases in India. BMJ (1995) 3.38

At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci U S A (1993) 3.37

Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med (1975) 3.31

Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet (1980) 3.31

Australia antigen: large-scale purification from human serum and biochemical studies of its proteins. J Virol (1971) 3.28

Field testing and comparative evaluation of rapid, visually read screening assays for antibody to human immunodeficiency virus. Lancet (1989) 3.18

Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect Immun (1981) 3.18

Diagnosis of Chlamydia trachomatis infections by direct immunofluorescence staining of genital secretions. A multicenter trial. Ann Intern Med (1984) 3.15

The polymicrobial origin of intestinal infections in homosexual men. N Engl J Med (1983) 3.12

Unrecognized human immunodeficiency virus infection in emergency department patients. N Engl J Med (1988) 3.08

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol (1994) 3.06

ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis (1993) 3.06

Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature (1984) 3.03

A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature (1983) 3.02

Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02

Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique. J Immunol (1971) 2.98

Microtiter solid-phase radioimmunoassay for hepatitis B antigen. Appl Microbiol (1973) 2.96

Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci U S A (1983) 2.92

Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Natl Acad Sci U S A (1984) 2.87

The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol (1993) 2.84

Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J Virol (1987) 2.83

Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci U S A (1994) 2.83

Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect Immun (1984) 2.81

A color test for the measurement of antibody to the non-acid-forming human Mycoplasma species. Am J Epidemiol (1966) 2.81

Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol (1998) 2.81

Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol (2000) 2.80

Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med (1998) 2.78

Transmissible agent in non-A, non-B hepatitis. Lancet (1978) 2.78

Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science (1979) 2.78

Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. Virology (1998) 2.76

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol (2000) 2.73

Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc Natl Acad Sci U S A (2000) 2.70

Compact organization of the hepatitis B virus genome. Hepatology (1989) 2.70

Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. JAMA (1986) 2.69

Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis (1987) 2.68

Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med (2001) 2.68

Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med (1976) 2.67

Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65